PURPOSE: Amphibian retinas regenerate after injury, making them ideal for studying the mechanisms of retinal regeneration, but this leaves their value as models of retinal degeneration in question. The authors asked whether the initial cellular changes after rod loss in the regenerative model Xenopus laevis mimic those observed in nonregenerative models. They also asked whether rod loss was reversible. METHODS: The authors generated transgenic X. laevis expressing the Escherichia coli enzyme nitroreductase (NTR) under the control of the rod-specific rhodopsin (XOP) promoter. NTR converts the antibiotic metronidazole (Mtz) into an interstrand DNA cross-linker. A visually mediated behavioral assay and immunohistochemistry were used to determine the effects of Mtz on the vision and retinas of XOPNTR F1 tadpoles. RESULTS: NTR expression was detected only in the rods of XOPNTR tadpoles. Mtz treatment resulted in rapid vision loss and near complete ablation of rod photoreceptors by day 12. Müller glial cell hypertrophy and progressive cone degeneration followed rod cell ablation. When animals were allowed to recover, new rods were born and formed outer segments. CONCLUSIONS: The initial secondary cellular changes detected in the rodless tadpole retina mimic those observed in other models of retinal degeneration. The rapid and synchronous rod loss in XOPNTR animals suggested this model may prove useful in the study of retinal degeneration. Moreover, the regenerative capacity of the Xenopus retina makes these animals a valuable tool for identifying the cellular and molecular mechanisms at work in lower vertebrates with the remarkable capacity of retinal regeneration.
PURPOSE: Amphibian retinas regenerate after injury, making them ideal for studying the mechanisms of retinal regeneration, but this leaves their value as models of retinal degeneration in question. The authors asked whether the initial cellular changes after rod loss in the regenerative model Xenopus laevis mimic those observed in nonregenerative models. They also asked whether rod loss was reversible. METHODS: The authors generated transgenic X. laevis expressing the Escherichia coli enzyme nitroreductase (NTR) under the control of the rod-specific rhodopsin (XOP) promoter. NTR converts the antibiotic metronidazole (Mtz) into an interstrand DNA cross-linker. A visually mediated behavioral assay and immunohistochemistry were used to determine the effects of Mtz on the vision and retinas of XOPNTR F1 tadpoles. RESULTS: NTR expression was detected only in the rods of XOPNTR tadpoles. Mtz treatment resulted in rapid vision loss and near complete ablation of rod photoreceptors by day 12. Müller glial cell hypertrophy and progressive cone degeneration followed rod cell ablation. When animals were allowed to recover, new rods were born and formed outer segments. CONCLUSIONS: The initial secondary cellular changes detected in the rodless tadpole retina mimic those observed in other models of retinal degeneration. The rapid and synchronous rod loss in XOPNTR animals suggested this model may prove useful in the study of retinal degeneration. Moreover, the regenerative capacity of the Xenopus retina makes these animals a valuable tool for identifying the cellular and molecular mechanisms at work in lower vertebrates with the remarkable capacity of retinal regeneration.
Authors: B Chang; N L Hawes; M T Pardue; A M German; R E Hurd; M T Davisson; S Nusinowitz; K Rengarajan; A P Boyd; S S Sidney; M J Phillips; R E Stewart; R Chaudhury; J M Nickerson; J R Heckenlively; J H Boatright Journal: Vision Res Date: 2007-01-30 Impact factor: 1.886
Authors: Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Elizabeth A M Windsor; Waldo Herrera; D Alan White; Shalesh Kaushal; Anjani Naidu; Alejandro J Roman; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 2008-04 Impact factor: 4.799
Authors: Ryan Thummel; Sean C Kassen; Jacob E Montgomery; Jennifer M Enright; David R Hyde Journal: Dev Neurobiol Date: 2008-02-15 Impact factor: 3.964
Authors: Ferdinand Kaya; Abdelkrim Mannioui; Albert Chesneau; Sowmya Sekizar; Emmanuelle Maillard; Chantal Ballagny; Ludivine Houel-Renault; David Dupasquier; Odile Bronchain; Isabelle Holtzmann; Anne Desmazieres; Jean-Léon Thomas; Barbara A Demeneix; Peter J Brophy; Bernard Zalc; Andre Mazabraud Journal: J Neurosci Date: 2012-09-12 Impact factor: 6.167
Authors: Gabriele Di Sante; Liping Wang; Chenguang Wang; Xuanmiao Jiao; Mathew C Casimiro; Ke Chen; Timothy G Pestell; Ismail Yaman; Agnese Di Rocco; Xin Sun; Yoshiyuki Horio; Michael J Powell; Xiaohong He; Michael W McBurney; Richard G Pestell Journal: Mol Endocrinol Date: 2014-12-29
Authors: Damian C Lee; Felix R Vazquez-Chona; W Drew Ferrell; Beatrice M Tam; Bryan W Jones; Robert E Marc; Orson L Moritz Journal: J Neurosci Date: 2012-02-08 Impact factor: 6.167
Authors: Reyna I Martinez-De Luna; Ray Y Ku; Alexandria M Aruck; Francesca Santiago; Andrea S Viczian; Diego San Mauro; Michael E Zuber Journal: Dev Biol Date: 2016-03-18 Impact factor: 3.582